insights_auto
Why is CONCORDBIO up 2.19%?
Dive Deeperchevron_right
CONCORDBIO:NSE
Concord Biotech Ltd
₹1,360.00
arrow_upward
+2.19%(+29.20) 1D
Oct 9, 3:30:01 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CONCORDBIO...
Open
₹1,336.00
High
₹1,370.00
Low
₹1,326.00
Mkt. cap
142.28B
Avg. vol.
146.28K
Volume
128.35K
Dividend
0.56%
Quarterly dividend
₹1.89
Ex-dividend date
Jul 24, 2026
P/E ratio
51.69
52-wk high
₹1,627.00
52-wk low
₹987.00
EPS
₹26.31
No. of employees
2K
Open
₹1,336.00
High
₹1,370.00
Low
₹1,326.00
Mkt. cap
142.28B
Avg. vol.
146.28K
Volume
128.35K
Dividend
0.56%
Quarterly dividend
₹1.89
Ex-dividend date
Jul 24, 2026
P/E ratio
51.69
52-wk high
₹1,627.00
52-wk low
₹987.00
EPS
₹26.31
No. of employees
2K
News stories
From web sources and news partners
Simply Wall Street
·
30 minutes ago
Broadcom (AVGO) Is Leading A $50 Billion AI Chip Debt Push
The Globe and Mail
·
32 minutes ago
BTQ Technologies (NASDAQ: BTQ) (CBOE CA: BTQ) Named Security Partner for MoonPay Korea Stablecoin Infrastructure
Seeking Alpha
·
1 hour ago
The 1-Minute Market Report October 10, 2026 (NYSEARCA:VOO)
Profile
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide.
It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
About Concord Biotech Ltd